Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2022008712 - SYSTEM

Publication Number WO/2022/008712
Publication Date 13.01.2022
International Application No. PCT/EP2021/069138
International Filing Date 09.07.2021
IPC
G01N 33/50 2006.1
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
G01N 33/68 2006.1
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
Applicants
  • WISTA LABORATORIES LTD. [SG]/[SG]
  • HARRINGTON, Charles, Robert [GB]/[GB] (MG)
Inventors
  • HARRINGTON, Charles, Robert
  • POLLACK, Saskia, Julie
  • MARSHALL, Karen, Elizabeth
  • SERPELL, Louise, Charlotte
  • WISCHIK, Claude, Michel
Agents
  • NEWTON, Michael Jonathan
Priority Data
2010620.910.07.2020GB
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) SYSTEM
(FR) SYSTÈME
Abstract
(EN) The present invention provides a system for the study of tau protein aggregation in neuronal cells in vitro which can be used to screen agents for therapeutic effectiveness against aggregates of tau protein or fragments thereof.
(FR) La présente invention concerne un système pour l'étude de l'agrégation de protéine tau dans des cellules neuronales in vitro qui peut être utilisé pour cribler des agents pour une efficacité thérapeutique contre des agrégats de protéine tau ou de fragments de celle-ci.
Latest bibliographic data on file with the International Bureau